CS Group

CSL is a global biotechnology leader that develops and delivers innovative medicines for people with rare and serious diseases, as well as influenza vaccines. The company operates through three primary businesses: CSL Behring, which focuses on plasma-derived and recombinant therapeutic proteins; CSL Seqirus, one of the world's largest influenza vaccine providers; and CSL Vifor, a leader in iron deficiency and nephrology. CSL's extensive pipeline includes advanced gene therapies, next-generation vaccines, and monoclonal antibodies targeting a wide range of hematologic, immunologic, and cardiovascular conditions. With a significant global footprint and a history dating back to 1916, CSL is a major player in the life sciences industry, committed to addressing unmet medical needs through cutting-edge R&D and large-scale manufacturing.